$AMBQ

Chen Sean Chihhsiang sold $858K of AMBQ

Chen Sean Chihhsiang (President and COO) sold 15,000 shares of Ambiq Micro, Inc. (AMBQ) at an average of $57.17 ($57.09–$57.68, $0.86M total) across 2 trades on 2026-09-04 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Chen Sean Chihhsiang
Published Sep 9, 2026, 9:10 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 9, 2026, 9:49 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$AMBQ
Neutral
medium confidence
Mentioned
$AMBQ
Relevance
4/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$AMBQNeutralLow
01

Why it matters

The disclosed sale is modest and pre‑arranged, offering limited trading insight.

02

Market read

Routine insider sale with minimal market impact.

03

What to watch

Potential upcoming corporate actions or compensation plans not disclosed.

Relevance 4/10Novelty 3/10Timing: post‑market Sep 4 transaction, filed Sep 9

Background

Form 4 filing discloses insider transactions required by SEC regulations.

Company-level read

Ticker impact

$AMBQNeutralMedium confidence
Context

President and COO sold 15,000 shares for $857,558 via a 10b5‑1 plan.

Expected impact

Minimal short‑term impact; price likely unchanged.

Evidence & confidence

Sale amount is under $1M and follows a pre‑arranged plan, limiting informational value.

Market effects

No material effect on the semiconductor sector.

Limited to US investors tracking insider activity.

Negligible

Counterpoint

The sale could be a routine liquidity event rather than a lack of confidence.

Key entities

  • Ambiq Micro, Inc.

    US‑listed semiconductor company (NASDAQ: AMBQ).

  • Chen Sean Chihhsiang

    President and COO of Ambiq Micro.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

Med

Ambiq Micro, Inc. Q2 2026 Earnings Call Summary

Ambiq Micro reported Q2 2026 results and said revenue rose 90% year over year, driven by stronger Edge AI demand and growth across Apollo II and Apollo IV, with Apollo V more than doubling on a new large customer ramp. Management projected Q3 net sales up ~100% YoY and 2026 revenue about $135M, despite supply constraints limiting shipments. Gross margin expected to improve modestly in 2026.

Med

Ambiq Micro Q2 net loss narrows to US$7.1 million as edge AI sales surge

Ambiq Micro reported Q2 net loss of $7.1 million, or $0.32 per share, narrowing from $8.5 million a year earlier, as revenue rose 89.7% on stronger demand for ultra-low power edge AI chips. Q2 gross profit more than doubled to $15.3 million and gross margin rose to 45%. H1 net loss was $17.3 million. Cash was $366.8 million after a June follow-on raising $167.9 million net proceeds.

$AMBQHighAI 9/10

Ambiq (AMBQ) Q2 2026 Earnings Call Transcript

Ambiq Micro (AMBQ) reported Q2 2026 net sales of $33.9 million, up 89.7% year over year, citing accelerating edge AI demand. Non-GAAP gross margin was 47.2%. Full-year net sales guidance is about $135 million, with Q3 revenue outlook of $36 million to $37 million. Management cited supply constraints limiting order fulfillment and said cash was $366.8 million as of June 30, 2026.